The online CME activity consisted of a 30-minute video discussion between 1 dementia expert,  1 neuroradiologist, 1 geriatrician, and 1 patient advocate. Educational effect was assessed by comparing responses to four identical questions presented before and directly after exposure to the intervention.  A paired samples t-test assessed the overall average number of correct responses and a McNemar’s test identified significant between pre- and post-differences in question responses. The educational effect size was calculated by Cohen’s d. Data were collected between March 2025 and June 2025.

Participation in the CME intervention resulted in a large educational effect size among neurologists (n=113; d=.88; p<0.001). Significant (P <.05) pre- vs post-educational improvements were demonstrated on the following: goals of treating early AD; patient selection factors for AATs; contraindications for AATs. Between 64%-72% correctly answered question on goals of treatment and patient selection factors prior to the intervention. Only 22% correctly answered a question on contraindications for AAT use prior to the intervention.  After participating in the intervention, 37% reported an increase in their confidence to speak with patients and families about the benefits and risks of AATs.